VYNE Therapeutics Inc. — Form D
VYNE Therapeutics Inc. of BRIDGEWATER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-16. The offering totals $88.2M, of which $88.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-16
- Form: D
- Accession: 0001231919-23-000071
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $88.2M
- Amount sold: $88.2M
- Investors: 19
- Date of first sale: 2023-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-497484
Issuer
- Name: VYNE Therapeutics Inc.
- CIK: 0001566044
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER, NJ, 08807
- Phone: 800-775-7936
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| SHARON BARBARI | Director | BRIDGEWATER, NJ |
| STEVEN BASTA | Director | BRIDGEWATER, NJ |
| ANTHONY BRUNO | Director | BRIDGEWATER, NJ |
| DAVID DOMZALSKI | Director | BRIDGEWATER, NJ |
| PATRICK LEPORE | Director | BRIDGEWATER, NJ |
| ELISABETH SANDOVAL | Director | BRIDGEWATER, NJ |
| DAVID DOMZALSKI | Executive Officer | BRIDGEWATER, NJ |
| MUTYA HARSCH | Executive Officer | BRIDGEWATER, NJ |
| IAIN STUART | Executive Officer | BRIDGEWATER, NJ |
| TYLER ZERONDA | Executive Officer | BRIDGEWATER, NJ |
| Andrew Perlman | Director | Atlanta, GA |
| Ketan L Patel | Director | Calabasas, CA |
| James Larrick | Director | Osage Beach, MO |
| James Larrick | Executive Officer | Osage Beach, MO |
| Albert L Cha | Director | Menlo Park, CA |
| Steven L Basta | Director | Menlo Park, CA |
| Steven L Basta | Executive Officer | Menlo Park, CA |
| John L Creecy | Director | Menlo Park, CA |
| Scott L Whitcup | Director | Menlo Park, CA |
| Aaron L Royston | Director | Menlo Park, CA |
| Ted L Ebel | Director | Menlo Park, CA |
| David L Collier | Director | Menlo Park, CA |
| Edward Schnipper | Director | Grand Prairie, TX |
Other filings by this issuer (3)
More